Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320 (original) (raw)

References

  1. Mueller, M. M. & Fusenig, N. E. Friends or foes—bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 4, 839–849 (2004).
    Article CAS Google Scholar
  2. Bhowmick, N. A., Neilson, E. G. & Moses, H. L. Stromal fibroblasts in cancer initiation and progression. Nature 432, 332–337 (2004).
    Article CAS Google Scholar
  3. Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nat. Rev. Cancer 6, 392–401 (2006).
    Article CAS Google Scholar
  4. Eswarakumar, V. P., Lax, I. & Schlessinger, J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 16, 139–149 (2005).
    Article CAS Google Scholar
  5. Sotgia, F. et al. Caveolin-1−/− null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts. Am. J. Pathol. 174, 746–761 (2009).
    Article CAS Google Scholar
  6. Trimboli, A. J. et al. Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 461, 1084–1091 (2009).
    Article CAS Google Scholar
  7. Di Leva, G. & Croce, C. M. Roles of small RNAs in tumor formation. Trends Mol. Med. 16, 257–267.
  8. Ventura, A. & Jacks, T. MicroRNAs and cancer: short RNAs go a long way. Cell 136, 586–591 (2009).
    Article CAS Google Scholar
  9. Trimboli, A. J. et al. Direct evidence for epithelial–mesenchymal transitions in breast cancer. Cancer Res. 68, 937–945 (2008).
    Article CAS Google Scholar
  10. Bader, A. G., Brown, D. & Winkler, M. The promise of microRNA replacement therapy. Cancer Res. 70, 7027–7030 (2010).
    Article CAS Google Scholar
  11. Zhang, L. et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl Acad. Sci. USA 103, 9136–9141 (2006).
    Article CAS Google Scholar
  12. Ichimi, T. et al. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int. J. Cancer 125, 345–352 (2009).
    Article CAS Google Scholar
  13. Schepeler, T. et al. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res. 68, 6416–6424 (2008).
    Article CAS Google Scholar
  14. Mattie, M. D. et al. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol. Cancer 5, 24 (2006).
    Article Google Scholar
  15. Yan, L. X. et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14, 2348–2360 (2008).
    Article CAS Google Scholar
  16. Borowsky, A. D. et al. Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior. Clin. Exp. Metastasis 22, 47–59 (2005).
    Article CAS Google Scholar
  17. Nuovo, G. J. In situ detection of precursor and mature microRNAs in paraffin embedded, formalin fixed tissues and cell preparations. Methods 44, 39–46 (2008).
    Article CAS Google Scholar
  18. Jorgensen, S., Baker, A., Moller, S. & Nielsen, B. S. Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes. Methods 52, 375–381 (2010).
    Article CAS Google Scholar
  19. Nuovo, G., Lee, E. J., Lawler, S., Godlewski, J. & Schmittgen, T. In situ detection of mature microRNAs by labeled extension on ultramer templates. Biotechniques 46, 115–126 (2009).
    Article CAS Google Scholar
  20. Obernosterer, G., Leuschner, P. J., Alenius, M. & Martinez, J. Post-transcriptional regulation of microRNA expression. RNA 12, 1161–1167 (2006).
    Article CAS Google Scholar
  21. Politz, J. C., Hogan, E. M. & Pederson, T. MicroRNAs with a nucleolar location. RNA 15, 1705–1715 (2009).
    Article CAS Google Scholar
  22. Kim, D. H., Saetrom, P., Snove, O. Jr & Rossi, J. J. MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc. Natl Acad. Sci. USA 105, 16230–16235 (2008).
    Article CAS Google Scholar
  23. Huber, M. A., Kraut, N. & Beug, H. Molecular requirements for epithelial–mesenchymal transition during tumor progression. Curr. Opin. Cell Biol. 17, 548–558 (2005).
    Article CAS Google Scholar
  24. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000).
    Article CAS Google Scholar
  25. Hughes, C. C. Endothelial–stromal interactions in angiogenesis. Curr. Opin. Hematol. 15, 204–209 (2008).
    Article Google Scholar
  26. Orlichenko, L. S. & Radisky, D. C. Matrix metalloproteinases stimulate epithelial–mesenchymal transition during tumor development. Clin. Exp. Metastasis 25, 593–600 (2008).
    Article CAS Google Scholar
  27. Mongiat, M. et al. The extracellular matrix glycoprotein elastin microfibril interface located protein 2: a dual role in the tumor microenvironment. Neoplasia 12, 294–304 (2010).
    Article CAS Google Scholar
  28. Aoyama, T. et al. Structure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene. Biochem. J. 339, 177–184 (1999).
    Article CAS Google Scholar
  29. Yan, S., Berquin, I. M., Troen, B. R. & Sloane, B. F. Transcription of human cathepsin B is mediated by Sp1 and Ets family factors in glioma. DNA Cell Biol. 19, 79–91 (2000).
    Article CAS Google Scholar
  30. Cironi, L. et al. IGF1 is a common target gene of Ewing’s sarcoma fusion proteins in mesenchymal progenitor cells. PLoS One 3, e2634 (2008).
    Article Google Scholar
  31. He, H. J., Kole, S, Kwon, Y. K., Crow, M. T. & Bernier, M. Interaction of filamin A with the insulin receptor alters insulin-dependent activation of the mitogen-activated protein kinase pathway. J. Biol. Chem. 278, 27096–27104 (2003).
    Article CAS Google Scholar
  32. de Kerchove D’Exaerde, A. et al. Expression of mutant Ets protein at the neuromuscular synapse causes alterations in morphology and gene expression. EMBO Rep. 3, 1075–1081 (2002).
    Article Google Scholar
  33. Tomarev, S. I. & Nakaya, N. Olfactomedin domain-containing proteins: possible mechanisms of action and functions in normal development and pathology. Mol. Neurobiol. 40, 122–138 (2009).
    Article CAS Google Scholar
  34. Hollander, M. C., Blumenthal, G. M. & Dennis, P. A. PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat. Rev. Cancer 11, 289–301 (2011).
    Article CAS Google Scholar
  35. Rong, Y. et al. Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity. Cancer Res. 69, 2540–2549 (2009).
    Article CAS Google Scholar
  36. Vivanco, I. et al. Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN. Cancer Cell 11, 555–569 (2007).
    Article CAS Google Scholar
  37. Finak, G. et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat. Med. 14, 518–527 (2008).
    Article CAS Google Scholar
  38. Finak, G. et al. Gene expression signatures of morphologically normal breast tissue identify basal-like tumors. Breast Cancer Res. 8, R58 (2006).
    Article Google Scholar
  39. Pawitan, Y. et al. Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res. 7, R953–R964 (2005).
    Article CAS Google Scholar
  40. Todaro, G. J. & Green, H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17, 299–313 (1963).
    Article CAS Google Scholar
  41. Hunter, M. P. et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3, e3694 (2008).
    Article Google Scholar
  42. Godlewski, J. et al. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 68, 9125–9130 (2008).
    Article CAS Google Scholar
  43. Godlewski, J. et al. MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. Mol. Cell 37, 620–632 (2010).
    Article CAS Google Scholar
  44. Nowicki, M. O. et al. Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3. Neuro. Oncol. 10, 690–699 (2008).
    Article CAS Google Scholar
  45. Rothhammer, T., Bataille, F., Spruss, T., Eissner, G. & Bosserhoff, A. K. Functional implication of BMP4 expression on angiogenesis in malignant melanoma. Oncogene 26, 4158–4170 (2007).
    Article CAS Google Scholar
  46. Srinivasan, R. et al. Erk1 and Erk2 regulate endothelial cell proliferation and migration during mouse embryonic angiogenesis. PLoS One 4, e8283 (2009).
    Article Google Scholar
  47. Chong, J. L. et al. E2f1–3 switch from activators in progenitor cells to repressors in differentiating cells. Nature 462, 930–934 (2009).
    Article CAS Google Scholar
  48. Bronisz, A. et al. Microphthalmia-associated transcription factor interactions with 14-3-3 modulate differentiation of committed myeloid precursors. Mol. Biol. Cell 17, 3897–3906 (2006).
    Article CAS Google Scholar
  49. Holm, S. A simple sequentially rejective multiple test procedure. Scand. J. Stat. 6, 65–70 (1979).
    Google Scholar

Download references

Acknowledgements

We thank Kara Batte for technical assistance with the microRNA platform, Rumeysa Biyik for bioinformatics assistance, Abdel-Rasoul Mahmoud for statistical assistance and the Ohio State University Human Tissue Resource Network and the Ohio State University Comprehensive Cancer Center Microarray, Nucleic Acids, Proteomic Shared Facilities for technical assistance. This work was funded by grants from the National Institutes of Health to M.C.O. (R01CA053271, P01CA097189) and to G.L. (R01CA85619, R01HD47470, P01CA097189) and from the Komen Breast Cancer Foundation and Evelyn Simmers Charitable Trust to M.C.O.

Author information

Authors and Affiliations

  1. Tumor Microenvironment Program, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA
    A. Bronisz, G. Leone & M. C. Ostrowski
  2. Department of Molecular and Cellular Biochemistry, College of Medicine, The Ohio State University, Columbus, Ohio 43210, USA
    A. Bronisz, J. A. Wallace, A.S. Merchant, H. Mathsyaraja, R. Srinivasan, C. K. Martin, F. Li & M. C. Ostrowski
  3. Department of Neurological Surgery, Dardinger Laboratory for Neuro-oncology and Neurosciences, The Ohio State University Medical Center and James Comprehensive Cancer Center, Columbus, Ohio 43210, USA
    J. Godlewski, M.O. Nowicki, S. E. Lawler & E. A. Chiocca
  4. Department of Molecular Genetics, College of Biological Sciences, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio 43210, USA
    A. J. Trimboli, F. Li, T. Pécot & G. Leone
  5. Department of Molecular Virology, Immunology and Medical Genetics, Ohio State University, Columbus, Ohio 43210, USA
    A. J. Trimboli, T. Pécot & G. Leone
  6. Center for Biostatistics, Office of Health Sciences, The Ohio State University, Columbus, Ohio 43210, USA
    L. Yu & S. A. Fernandez
  7. The Ohio State University Computer Science and Engineering, The Ohio State University Biomedical Informatics, The Ohio State University, Columbus, Ohio 43210, USA
    T. Pécot
  8. Department of Veterinary Clinical Sciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio 43210, USA
    T. J. Rosol
  9. McGill Centre for Bioinformatics, McGill University, Montreal, Quebec, H3A0B1, Canada
    S. Cory & M. Hallett
  10. Department of Biochemistry, Rosalind and Morris Goodman Cancer Center University, Montreal, Quebec, H3A0B, Canada
    S. Cory, M. Hallett & M. Park
  11. Department of Oncology, McGill University, Quebec, H3A 1A1, Canada
    M. Park
  12. Division of Pulmonary, Department of Internal Medicine, Allergy, Critical Care, and Sleep Medicine, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio 43210, USA
    M. G. Piper & C. B. Marsh
  13. Department of Surgery, School of Medicine, The Ohio State University, Columbus, Ohio 43210, USA
    L. D. Yee
  14. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA
    R. E. Jimenez
  15. Department of Pathology, The Ohio State University Medical Center and James Comprehensive Cancer Center, Columbus, Ohio 43210, USA
    G. Nuovo

Authors

  1. A. Bronisz
    You can also search for this author inPubMed Google Scholar
  2. J. Godlewski
    You can also search for this author inPubMed Google Scholar
  3. J. A. Wallace
    You can also search for this author inPubMed Google Scholar
  4. A.S. Merchant
    You can also search for this author inPubMed Google Scholar
  5. M.O. Nowicki
    You can also search for this author inPubMed Google Scholar
  6. H. Mathsyaraja
    You can also search for this author inPubMed Google Scholar
  7. R. Srinivasan
    You can also search for this author inPubMed Google Scholar
  8. A. J. Trimboli
    You can also search for this author inPubMed Google Scholar
  9. C. K. Martin
    You can also search for this author inPubMed Google Scholar
  10. F. Li
    You can also search for this author inPubMed Google Scholar
  11. L. Yu
    You can also search for this author inPubMed Google Scholar
  12. S. A. Fernandez
    You can also search for this author inPubMed Google Scholar
  13. T. Pécot
    You can also search for this author inPubMed Google Scholar
  14. T. J. Rosol
    You can also search for this author inPubMed Google Scholar
  15. S. Cory
    You can also search for this author inPubMed Google Scholar
  16. M. Hallett
    You can also search for this author inPubMed Google Scholar
  17. M. Park
    You can also search for this author inPubMed Google Scholar
  18. M. G. Piper
    You can also search for this author inPubMed Google Scholar
  19. C. B. Marsh
    You can also search for this author inPubMed Google Scholar
  20. L. D. Yee
    You can also search for this author inPubMed Google Scholar
  21. R. E. Jimenez
    You can also search for this author inPubMed Google Scholar
  22. G. Nuovo
    You can also search for this author inPubMed Google Scholar
  23. S. E. Lawler
    You can also search for this author inPubMed Google Scholar
  24. E. A. Chiocca
    You can also search for this author inPubMed Google Scholar
  25. G. Leone
    You can also search for this author inPubMed Google Scholar
  26. M. C. Ostrowski
    You can also search for this author inPubMed Google Scholar

Contributions

M.C.O. and G.L. designed and supervised this study, analysed data and helped write and edit the manuscript. A.B. and J.G. designed and carried out experiments, collected and analysed data and co-wrote the paper. J.A.W., H.M., R.S., A.J.T. and F.L. assisted technically with experiments, and collected and analysed data. M.O.N. assisted with fluorescent and confocal microscopy and immunohistochemistry. L.Y. and S.A.F. contributed to the statistical analyses of data and writing the manuscript. A.S.M., S.C., M.H., M.P. and T.P. contributed to the analysis and comparison of mouse and human profile data. M.G.P. and C.B.M. contributed to the analysis of microRNA data and writing the manuscript. C.K.M., L.D.Y., R.E.J., G.N. and T.J.R. contributed to the histopathological analysis of human samples and writing the manuscript. S.E.L. and E.A.C. contributed to the data analysis and writing the manuscript.

Corresponding authors

Correspondence toG. Leone or M. C. Ostrowski.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Rights and permissions

About this article

Cite this article

Bronisz, A., Godlewski, J., Wallace, J. et al. Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320.Nat Cell Biol 14, 159–167 (2012). https://doi.org/10.1038/ncb2396

Download citation